Metraipolis › archive › dc_12f968f41765
SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications — Europe PMC PMID:42814168
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42814168
- DOI
- 10.1186/s43556-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T18:08:02.838Z
- SHA-256 of the archived text
9b8ed46a798a4cb5914eb2b1bd00490a10c664f45cfd5e6cef33e91abb108675- Stable URL of this page
https://metraipolis.com/documento/dc_12f968f41765
How to cite
SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications — Europe PMC PMID:42814168 — Europe PMC (en), https://europepmc.org/article/MED/42814168 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_12f968f41765 (Metraipolis archive dc_12f968f41765, sha256 9b8ed46a798a4cb5914eb2b1bd00490a10c664f45cfd5e6cef33e91abb108675)
BibTeX
@misc{dc12f968f41765,
title = {SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications — Europe PMC PMID:42814168},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42814168},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_12f968f41765; sha256 9b8ed46a798a4cb5914eb2b1bd00490a10c664f45cfd5e6cef33e91abb108675},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42814168. Agents can read the archived copy with the MCP tool read_document.